Hinova Pharmaceuticals, Inc. Class ASSE: 688302

Announcement on Convening the Q3 2024 Performance Briefing

Nov 5, 2024 · Issued by Hinova Pharmaceuticals, Inc. Class A via Shanghai Stock Exchange

Announcement on Convening the Q3 2024 Performance Briefing

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment